The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 dose-escalation and -expansion study of IMP7068, a WEE1 inhibitor, in patients with advanced solid tumors.
 
Chia-Chi Lin
Honoraria - Daiichi Sankyo; Lilly; Novartis; Novartis; Roche
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo; Novartis; PharmaEngine
Travel, Accommodations, Expenses - BeiGene; Daiichi Sankyo; Daiichi Sankyo; Lilly; Novartis
 
Jaspreet Singh Grewal
Consulting or Advisory Role - Eisai
Speakers' Bureau - BMS Brazil; Ipsen
 
David Sommerhalder
Employment - Texas Oncology
 
James Fredric Strauss
Leadership - Dialectic Therapeutics
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Bristol-Myers Squibb; Intuitive Surgical; Johnson & Johnson; Merck; Regeneron
Consulting or Advisory Role - Binhui Biopharmaceuticals, Ltd. (Inst); Synlogic (Inst)
 
Li-Yuan Bai
Honoraria - CStone Pharmaceuticals; Ipsen; Lilly; Ono Pharmaceutical; Pfizer; SynCoreBio
Consulting or Advisory Role - Bristol-Myers Squibb; Zai Lab
Research Funding - Eisai
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squib; Daiichi Sankyo; Harbour BioMed; Merck; Mingji biopharmaceutical; MSD; Roche
Speakers' Bureau - Hutchison Whampoa; MSD
Research Funding - Baiji Shenzhou (Beijing) Biotechnology (Inst); Beijing Xiantong Biomedical Technology (Inst); Nanjing Yaojieankang Biotechnology (Inst); QiLu Pharmaceutical (Inst); Zaiding Pharmaceutical (Inst)
 
Yu-Min Yeh
Speakers' Bureau - Amgen
 
Chih-Yi Hsieh
Employment - ASLAN Pharmaceuticals; IMPAC Medical Systems
Leadership - ASLAN Pharmaceuticals; IMPAC Medical Systems
Stock and Other Ownership Interests - ASLAN Pharmaceuticals; IMPAC Medical Systems
 
Sui Xiong Cai
Employment - IMPAC Medical Systems
Leadership - IMPAC Medical Systems
Stock and Other Ownership Interests - IMPAC Medical Systems
 
Ye Edward Tian
Employment - IMPAC Medical Systems
Leadership - IMPAC Medical Systems
Stock and Other Ownership Interests - IMPAC Medical Systems
Patents, Royalties, Other Intellectual Property - IMPAC Medical Systems (Inst)
 
Huan Xia
Employment - IMPAC Medical Systems
Stock and Other Ownership Interests - IMPAC Medical Systems
 
Congcong Zhang
Employment - IMPAC Medical Systems
Honoraria - IMPAC Medical Systems
Patents, Royalties, Other Intellectual Property - IMPAC Medical Systems (Inst)
Travel, Accommodations, Expenses - IMPAC Medical Systems
 
Baoyue Li
Employment - IMPAC Medical Systems
 
Ming Zhang
Employment - IMPAC Medical Systems
Stock and Other Ownership Interests - IMPAC Medical Systems
 
Ning Ma
Employment - IMPAC Medical Systems
Leadership - IMPAC Medical Systems
Stock and Other Ownership Interests - IMPAC Medical Systems
 
Liping Zhao
Employment - IMPAC Medical Systems
Patents, Royalties, Other Intellectual Property - IMPAC Medical Systems (Inst)
Travel, Accommodations, Expenses - IMPAC Medical Systems
 
Jie Ma
Employment - IMPAC Medical Systems
Stock and Other Ownership Interests - IMPAC Medical Systems
Honoraria - IMPAC Medical Systems
Travel, Accommodations, Expenses - IMPAC Medical Systems
 
Huiyan Shi
Employment - IMPAC Medical Systems
 
Zhixin Yu
Employment - IMPAC Medical Systems
Honoraria - IMPAC Medical Systems
Patents, Royalties, Other Intellectual Property - IMPAC Medical Systems (Inst)
Travel, Accommodations, Expenses - IMPAC Medical Systems